§ 13F · FUND PROFILE
Davern Capital Partners, LP.
AUM · $587M (13F)Positions · 15Turnover · n/a · Q2Filed · Aug 13, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$64M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | BNTX | BIONTECH SE | 755K | $70M | 12.0% | +147% |
| 2 | ROIV | ROIVANT SCIENCES LTD | 1.93M | $68M | 11.7% | +121% |
| 3 | RPRX | ROYALTY PHARMA PLC | 1.16M | $65M | 11.0% | +122% |
| 4 | IONS | IONIS PHARMACEUTICALS INC | 799K | $63M | 10.8% | +106% |
| 5 | INSM | INSMED INC | 560K | $60M | 10.2% | +207% |
| 6 | REGN | REGENERON PHARMACEUTICALS | 93K | $58M | 9.8% | +107% |
| 7 | LEGN | LEGEND BIOTECH CORP | 1.19M | $34M | 5.9% | −9% |
| 8 | ALNY | ALNYLAM PHARMACEUTICALS INC | 113K | $34M | 5.8% | NEW |
| 9 | NTRA | NATERA INC | 119K | $32M | 5.5% | −17% |
| 10 | GPCR | STRUCTURE THERAPEUTICS INC | 446K | $24M | 4.1% | +253% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE DAVERN SIGNAL
AC read
Davern Capital Partners, LP is a Other fund managing $587 million in assets. The fund runs a focused portfolio of just 15 positions.
Read the full dossier →